- Home
- LH
as 10-17-2024 4:00pm EST
Laboratory Corp. of America is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.
Upcoming Earnings Alert:
Get ready for potential market movements as Laboratory Corporation of America Holdings LH prepares to release earnings report on 24 Oct 2024.
| Founded: | 1971 | Country: | United States |
| Employees: | N/A | City: | BURLINGTON |
| Market Cap: | 18.8B | IPO Year: | N/A |
| Target Price: | $252.60 | AVG Volume (30 days): | 442.3K |
| Analyst Decision: | Buy | Number of Analysts: | 16 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 5.27 | EPS Growth: | -43.27 |
| 52 Week Low/High: | $191.97 - $238.47 | Next Earning Date: | 10-24-2024 |
| Revenue: | $12,487,600,000 | Revenue Growth: | 5.22% |
| Revenue Growth (this year): | 9.8% | Revenue Growth (next year): | 5.67% |
Stock Insider Trading Activity of Laboratory Corporation of America Holdings (LH)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| EISENBERG GLENN A | LH | Chief Financial Officer, EVP | Aug 15 '24 | Sell | $223.61 | 15,000 | $3,359,824.58 | 43,310 | |
| BERBERIAN LANCE | LH | EVP, CIO & CTO | Aug 5 '24 | Sell | $229.37 | 12,093 | $2,770,552.15 | 25,769 |
Latest Laboratory Corporation of America Holdings News
LH Breaking Stock News: Dive into LH Ticker-Specific Updates for Smart Investing
Business Wire
2 days ago
NOWDiagnostics and Labcorp Collaborate to Expand Access to the Only FDA-Marketing Authorized Over-the-Counter Syphilis Test in the U.S.
Zacks
4 days ago
Labcorp's Q3 Earnings Looms: Here's What to Expect From the Stock
Argus Research
7 days ago
Big Finish to 3Q24
PR Newswire
8 days ago
Labcorp Expands Sexually Transmitted Infection (STI) Test Offerings with Rapid Syphilis Test
PR Newswire
8 days ago
Labcorp Declares Quarterly Dividend
Zacks
10 days ago
Labcorp Stock Gains From Biopharma Business Amid FX Woe
The Fly
17 days ago
Meta, Alphabet initiated: Wall Street's top analyst calls
Zacks
23 days ago
Should You Continue to Retain LH Stock in Your Portfolio?
Compare LH vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "LH Laboratory Corporation of America Holdings - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.